Donor leukocyte infusions in myeloid malignancies: new strategies
- 31 December 2006
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 19 (4), 737-755
- https://doi.org/10.1016/j.beha.2006.05.003
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulationBlood, 2006
- Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and MyelodysplasiaJournal of Clinical Oncology, 2005
- Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell TransplantationThe Journal of Experimental Medicine, 2004
- Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesBlood, 2004
- Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndromeBone Marrow Transplantation, 2004
- Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcomeBone Marrow Transplantation, 2000
- Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donorsBone Marrow Transplantation, 1998
- Adoptive Immunotherapy for Relapsed Leukemia Following Allogeneic Bone Marrow TransplantationLeukemia & Lymphoma, 1995
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979